BAC vs BGLC · P/E 13, rev $113.10B vs rev $9.5M
Bank of America Corp (BAC) versus BioNexus Gene Lab Corp Common stock (BGLC) — a side-by-side from cached financials, not a winner call.
Bank of America Corp (BAC) is a banks - diversified company listed on US. It is led by Brian Moynihan.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
Latest reported BAC revenue for 2025-12-31 was $113.10B. Net income was $30.51B. Revenue was up 11.0% from 2024-12-31 to 2025-12-31. BAC currently screens at market cap $382.01B and trailing P/E 13.4.
Latest reported BGLC revenue for 2024-12-31 was $9.5M. Net income was $1.6M. Revenue was down 2.7% from 2023-12-31 to 2024-12-31. BGLC currently screens at market cap $6.1M.
BAC currently screens at market cap $382.01B and trailing P/E 13.4. BGLC currently screens at market cap $6.1M.
Not investment advice. Open the BAC and BGLC stock pages for the full models.
Not investment advice.